Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEUROMETRIX-INC-34897119/news/NeuroMetrix-Reports-that-Quell-Technology-is-to-be-Evaluated-for-Neuromyelitis-Optica-Spectrum-Dis-35611196/?utm_source=whatsapp&utm_medium=social&utm_campaign=share